OBJECTIVES: Chlamydia trachomatis infection in the cervix and uterus has been hypothesised to be a co-factor for cervical cancer. We performed a cross sectional study in Bogota, Colombia, where cervical cancer rates are high, to determine the prevalence and determinants of C trachomatis infection, and in particular its association with human papillomavirus (HPV). METHODS: 1829 low income sexually active women were interviewed and tested for C trachomatis, using an endogenous plasmid PCR-EIA, and for 37 HPV types, using a general primer GP5+/6+ mediated PCR-EIA. RESULTS: The overall prevalence of C trachomatis was 5.0%, and it did not differ substantially between women with normal (5.0%) and those with abnormal (5.2%) cervical cytology. Women infected with any HPV type (15.1%) had a slightly increased risk of being simultaneously infected with C trachomatis (adjusted OR 1.3, 95% CI: 0.8 to 2.4). This association was stronger when multiple HPV infections (adjusted OR 2.5, 95% CI: 1.1 to 5.9) were present. No other lifestyle or reproductive characteristics were clearly associated with risk of C trachomatis infection. CONCLUSIONS: HPV infected women, particularly women with multiple HPV infections, are at increased risk of being infected with C trachomatis.
OBJECTIVES:Chlamydia trachomatis infection in the cervix and uterus has been hypothesised to be a co-factor for cervical cancer. We performed a cross sectional study in Bogota, Colombia, where cervical cancer rates are high, to determine the prevalence and determinants of C trachomatis infection, and in particular its association with human papillomavirus (HPV). METHODS: 1829 low income sexually active women were interviewed and tested for C trachomatis, using an endogenous plasmid PCR-EIA, and for 37 HPV types, using a general primer GP5+/6+ mediated PCR-EIA. RESULTS: The overall prevalence of C trachomatis was 5.0%, and it did not differ substantially between women with normal (5.0%) and those with abnormal (5.2%) cervical cytology. Women infected with any HPV type (15.1%) had a slightly increased risk of being simultaneously infected with C trachomatis (adjusted OR 1.3, 95% CI: 0.8 to 2.4). This association was stronger when multiple HPV infections (adjusted OR 2.5, 95% CI: 1.1 to 5.9) were present. No other lifestyle or reproductive characteristics were clearly associated with risk of C trachomatis infection. CONCLUSIONS:HPV infectedwomen, particularly women with multiple HPV infections, are at increased risk of being infected with C trachomatis.
Authors: L Grun; J Tassano-Smith; C Carder; A M Johnson; A Robinson; E Murray; J Stephenson; A Haines; A Copas; G Ridgway Journal: BMJ Date: 1997-07-26
Authors: C Ngelangel; N Muñoz; F X Bosch; G M Limson; M R Festin; J Deacon; M V Jacobs; M Santamaria; C J Meijer; J M Walboomers Journal: J Natl Cancer Inst Date: 1998-01-07 Impact factor: 13.506
Authors: N Chaouki; F X Bosch; N Muñoz; C J Meijer; B El Gueddari; A El Ghazi; J Deacon; X Castellsagué; J M Walboomers Journal: Int J Cancer Date: 1998-02-09 Impact factor: 7.396
Authors: Y T van Duynhoven; J M Ossewaarde; R P Derksen-Nawrocki; W I van der Meijden; M J van de Laar Journal: Clin Infect Dis Date: 1998-02 Impact factor: 9.079
Authors: S K Kjaer; A J van den Brule; J E Bock; P A Poll; G Engholm; M E Sherman; J M Walboomers; C J Meijer Journal: Cancer Epidemiol Biomarkers Prev Date: 1997-10 Impact factor: 4.254
Authors: S Chichareon; R Herrero; N Muñoz; F X Bosch; M V Jacobs; J Deacon; M Santamaria; V Chongsuvivatwong; C J Meijer; J M Walboomers Journal: J Natl Cancer Inst Date: 1998-01-07 Impact factor: 13.506
Authors: S A Morré; P T Sillekens; M V Jacobs; S de Blok; J M Ossewaarde; P van Aarle; B van Gemen; J M Walboomers; C J Meijer; A J van den Brule Journal: Mol Pathol Date: 1998-06
Authors: Koen D Quint; Leen-Jan van Doorn; Bernhard Kleter; Maurits N C de Koning; Henk A M van den Munckhof; Servaas A Morre; Bram ter Harmsel; Elisabete Weiderpass; Gonneke Harbers; Willem J G Melchers; Wim G V Quint Journal: J Mol Diagn Date: 2007-09-14 Impact factor: 5.568
Authors: Uma M Nagarajan; Daniel Prantner; James D Sikes; Charles W Andrews; Anna M Goodwin; Shanmugam Nagarajan; Toni Darville Journal: Infect Immun Date: 2008-07-28 Impact factor: 3.441
Authors: Segundo R León; Kelika A Konda; Jeffrey D Klausner; Franca R Jones; Carlos F Cáceres; Thomas J Coates Journal: Rev Panam Salud Publica Date: 2009-07
Authors: Katherine M E Turner; Elisabeth J Adams; Nigel Gay; Azra C Ghani; Catherine Mercer; W John Edmunds Journal: Theor Biol Med Model Date: 2006-01-20 Impact factor: 2.432
Authors: Edith Margarita Quinónez-Calvache; Dora Inés Ríos-Chaparro; Juan David Ramírez; Sara Cecilia Soto-De León; Milena Camargo; Luisa Del Río-Ospina; Ricardo Sánchez; Manuel Elkin Patarroyo; Manuel Alfonso Patarroyo Journal: PLoS One Date: 2016-01-25 Impact factor: 3.240